Pharmacological Activities of Polyherbal Formulations of Saraca asoca and its Substitute Plants: A Comparative Evaluation Study

ABSTRACT

Background: Saraca asoca (Roxb.) de Wild has been utilized in various commercial polyherbal preparations to treat gynecological disorders. Adulteration or replacement of similar raw pharmaceuticals is a widespread technique in its manufacture due to shortage. Objectives: The current study aimed to determine the pharmacological efficiency of Kingiodendron pinnatum and Cynometra travancorica as alternatives for S. asoca in Arishta formulations. Materials and Methods: Arishta was prepared using S. asoca and with the substitutes as per Ayurvedic Pharmacopoeia. The antiestrogenic activity, anti-inflammatory activity, and antioxidant activity of each Arishtam were evaluated. Results: After administering each Arishtam of dose 400 µl/kg body weight orally, when compared to normal, the estrogen level of Arishtam prepared with C. travancorica showed the greatest decrease (131.45 ± 10.62 pg/ml) compared to the other two groups. Upon oral administration of each Arishtam of doses 200 and 400 µl/kg body weight, the edema in the animal group administered with the higher dosage of Ashokarishtam was reduced by 65.88% when compared to the control. Arishtam prepared with K. pinnatum and C. travancorica showed 60% and 67.06% of inhibition, respectively. Each Arishtam also improved the antioxidant levels in both blood and liver. Conclusion: The study supports the use of K. pinnatum and C. travancorica as substitutes for S. asoca in Asokarishta and provides empirical support for Asokarishta in gynecological illnesses.

KEYWORDS

• Arishtam
• antiestrogenic activity
• anti-inflammatory activity
• Cynometra travancorica
• Kingiodendron pinnatum
• Saraca asoca

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X241309438Copy

RELATED ARTICLES

Matched on volume, issue, section and article type within J Pharmacol. Pharmacother..

• Article · VOLUME 16, ISSUE 3The Quality Evaluation of Antibiotics for the Treatment of Diabetic Foot Ulcers in the Intensive Care Unit of Public Private Hospital, Semarang CityGilang Rizki Al Farizi, A.A.P. Paramitha Vidiani, Fransisca Gloria, Dewi Karlina, Enggar Budi Astuti · pp. 274–282Original Research ArticleSame type: ArticleSame issue
• Article · VOLUME 16, ISSUE 3Benzoxazinone Derivatives as Antiplatelet: Synthesis, Molecular Docking, and Bleeding Time EvaluationKholis Amalia Nofianti, Juni Ekowati, Nuzul Wahyuning Diyah, Luqmanul Hakim · pp. 291–301Original Research ArticleSame type: ArticleSame issue
• Article · VOLUME 16, ISSUE 3Development and Validation of a Robust LC-MS/MS Method for Quantitation of a Novel Kinase Inhibitor, Ritlecitinib, in Rat Plasma: Application in Pharmacokinetic StudyKatari Pavan Kumar, Areti Anka Rao · pp. 302–310Original Research ArticleSame type: ArticleSame issue
• Article · VOLUME 16, ISSUE 3DNA Damage Underlies the Cytotoxic and Apoptotic Effects of Selected Ethiopian Medicinal Plants against Cancer Cell LinesAdamu T. Bekele, Sheila Almaraz Postigo, Kaleab Asres, Ephrem Engidawork, Atanasio Pandiella · pp. 311–323Original Research ArticleSame type: ArticleSame issue